Amacas Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Amacas General Information

Description

Developer of animal health pharmaceuticals intended to extend the health span of companion animals. The company offers a weight management pharmaceutical characterized by targeted formulation, controlled dosage, and veterinary applicability with a focus on addressing obesity-related conditions in pets, enabling veterinarians and pet owners to manage weight effectively while supporting longevity, improved quality of life, and overall health outcomes for companion animals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 44 Queen Street, Auckland Central
  • Auckland, 1010
  • New Zealand
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 44 Queen Street, Auckland Central
  • Auckland, 1010
  • New Zealand

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amacas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Jan-2026 Completed Startup
To view Amacas’s complete valuation and funding history, request access »

Amacas Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Amacas Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2026908473-A0 Amorphous pharmaceutical compositions and formulations of pi3k inhibitors Pending 09-Oct-2026

Amacas Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Auckland UniServices Corporate Venture Capital Minority
To view Amacas’s complete investors history, request access »

Ready to get started?

Request a free trial

Amacas FAQs

  • When was Amacas founded?

    Amacas was founded in 2025.

  • Where is Amacas headquartered?

    Amacas is headquartered in Auckland, New Zealand.

  • What industry is Amacas in?

    Amacas’s primary industry is Biotechnology.

  • Is Amacas a private or public company?

    Amacas is a Private company.

  • What is Amacas’s current revenue?

    The current revenue for Amacas is .

  • Who are Amacas’s investors?

    Auckland UniServices has invested in Amacas.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process